Over the past 12 months, 0 insiders at Oncocyte Corp filed 0 open-market SEC Form 4 transactions on OCX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 7, 25 | Andrea S. JamesChief Financial Officer | BUY | 97.6K | $2.05 | $200K |
| Feb 7, 25 | Patrick W SmithTenPercentOwner | BUY | 1.08M | $2.05 | $2.2M |
| Feb 6, 25 | Broadwood Partners, L.p.TenPercentOwner | BUY | 4.51M | $2.05 | $9.2M |
| Feb 4, 25 | Patrick W SmithTenPercentOwner | BUY | 25 | $2.02 | $51 |
| Jan 31, 25 | Patrick W SmithTenPercentOwner | BUY | 890 | $2.01 | $2K |
| Jan 30, 25 | Patrick W SmithTenPercentOwner | BUY | 318 | $2.01 | $639 |
| Jan 29, 25 | Patrick W SmithTenPercentOwner | BUY | 3.9K | $2.01 | $8K |
| Jan 14, 25 | Patrick W SmithTenPercentOwner | BUY | 10.3K | $2.15 | $22K |
| Jan 13, 25 | Patrick W SmithTenPercentOwner | BUY | 5.7K | $2.08 | $12K |
| Dec 26, 24 | Andrew ArnoDirector | BUY | 12.5K | $2.11 | $26K |
| Dec 26, 24 | Patrick W SmithTenPercentOwner | BUY | 90.2K | $2.13 | $192K |
| Dec 5, 24 | Andrea S. JamesChief Financial Officer | BUY | 20.0K | $2.29 | $46K |
| Oct 2, 24 | Broadwood Capital IncTenPercentOwner | BUY | 1.32M | $2.95 | $3.9M |
| Oct 2, 24 | Andrea S. JamesChief Financial Officer | BUY | 33.7K | $2.97 | $100K |
| Apr 11, 24 | Andrew ArnoDirector | BUY | 33.9K | $2.95 | $100K |
| Apr 11, 24 | Broadwood Partners, L.p.TenPercentOwner | BUY | 2.42M | $2.92 | $7.1M |
| Apr 11, 24 | Josh RiggsCEO and President | BUY | 3.4K | $2.95 | $10K |
| Jun 14, 23 | Alfred D KingsleyDirector | BUY | 30.0K | $0.21 | $6K |
| Apr 5, 23 | Pura Vida Investments, LlcTenPercentOwner | BUY | 663.0K | $0.30 | $199K |
| Apr 3, 23 | Broadwood Partners, L.p.TenPercentOwner | BUY | 26.83M | $0.30 | $8.0M |
| Dec 23, 22 | Andrew ArnoDirector | BUY | 250.0K | $0.35 | $88K |
| Dec 23, 22 | John Peter GutfreundDirector | BUY | 75.0K | $0.33 | $25K |
| Dec 22, 22 | Alfred D KingsleyDirector | BUY | 25.0K | $0.29 | $7K |
| Aug 17, 22 | Andrew ArnoDirector | BUY | 7.5K | $0.90 | $7K |
| Aug 17, 22 | Andrew J. LastDirector | BUY | 20.0K | $0.87 | $17K |
| Aug 16, 22 | Ronald Asbury AndrewsPresident & CEO | BUY | 40.0K | $0.96 | $38K |
| Aug 16, 22 | Andrew ArnoDirector | BUY | 115.5K | $0.97 | $112K |
| Aug 16, 22 | Jennifer L. CarterDirector | BUY | 10.5K | $0.95 | $10K |
| Aug 16, 22 | Melinda GriffithDirector | BUY | 10.0K | $1.00 | $10K |
| Aug 15, 22 | Andrew ArnoDirector | BUY | 34.5K | $0.93 | $32K |
| Aug 15, 22 | John Peter GutfreundDirector | BUY | 25.0K | $0.93 | $23K |
| Aug 15, 22 | Alfred D KingsleyDirector | BUY | 5.0K | $0.97 | $5K |
| Jun 24, 22 | Pura Vida Investments, LlcTenPercentOwner | SELL | 40.5K | $1.05 | $42K |
| May 18, 22 | Li YuVP Cntrllr/Prncpl Acctng Offcr | SELL | 8.1K | $1.14 | $9K |
| Apr 14, 22 | Efrem KamenTenPercentOwner | BUY | 92.4K | $1.26 | $116K |
| Apr 14, 22 | Pura Vida Investments, LlcTenPercentOwner | BUY | 1.92M | $1.33 | $2.5M |
| Apr 14, 22 | Broadwood Partners, L.p.TenPercentOwner | BUY | 6.00M | $1.33 | $8.0M |
| Mar 25, 22 | Douglas T. RossChief Scientific Officer | BUY | 15.0K | $1.40 | $21K |
| Mar 17, 22 | Gisela PaulsenChief Operating Officer | BUY | 16.5K | $1.20 | $20K |
| Mar 16, 22 | Cavan M. RedmondDirector | BUY | 40.0K | $1.19 | $48K |
| Mar 16, 22 | Ronald Asbury AndrewsChief Executive Officer | BUY | 50.0K | $1.28 | $64K |
| Mar 15, 22 | Mitchell S LevineChief Financial Officer | BUY | 25.0K | $1.17 | $29K |
Over the past 12 months, insiders at Oncocyte Corp filed 0 open-market purchases worth $0 and 0 sales worth $0 on OCX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market OCX insider purchase in our data was $9.2M by Broadwood Partners, L.p., TenPercentOwner, filed on Feb 6, 25.
0 different insiders at Oncocyte Corp filed open-market SEC Form 4 transactions on OCX over the last 12 months.
InsiderTape plots every OCX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Oncocyte Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →